Douglas G. Johns
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Douglas G. Johns has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Jong-Shiaw Jin
Department of Physiology, National Defense Medical Center, Taipei, People's Republic of China
2 shared publicationsR. Clinton Webb
CDATA[Departments of Physiology and Pediatrics, University of Michigan, Ann Arbor, Michigan, USA
2 shared publicationsDixon W. Wilde
Department of Physiology, University of Michigan, 7812 Medical Sciences Building II, Ann Arbor, MI, 48109-0622, USA
1 shared publicationJohn R. Charpie
CDATA[Departments of Physiology and Pediatrics, University of Michigan, Ann Arbor, Michigan, USA
1 shared publicationR.Clinton Webb
Department of Physiology, University of Michigan, 7812 Medical Sciences Building II, Ann Arbor, MI, 48109-0622, USA
1 shared publication
Latest Publications
- 4 November 1999
- Published by Elsevier in General Pharmacology: The Vascular System
- Vol. 33 (5) , 415-421
Ceramide-induced vasorelaxation An inhibitory action on protein kinase C
- 4 November 1999
- Published by Elsevier in General Pharmacology: The Vascular System
- Vol. 33 (5) , 415-421
Ceramide-induced vasorelaxation An inhibitory action on protein kinase C
- 1 December 1998
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Design
- Vol. 4 (6) , 481-488
Is Ceramide Signaling A Target for Vascular Therapeutic Intervention?
Today's society is plagued by cardiovascular diseases such as hypertension and atherosclerosis. Research devoted to the study of these diseases has focused, in part, on physiological phenomena responsible for the development and progression of the disease. Peripheral vascular function is one such focal point of research, and identification of cellular mechanisms that regulate vascular contractility and / or cellular proliferation is crucial for the development of new therapeutic interventions to combat these diseases. This review evaluates a new signaling mechanism, the ceramide signaling pathway as a potential target for therapeutic intervention. Special attention is given ceramide signaling in the contexts of vascular reactivity and cell proliferation in the vasculature. While ceramide signaling is a nascent area of vascular research, a growing body of evidence from other physiological systems implicates this new pathway as a potential regulator of contractile and cell proliferative functions within the blood vessel wall.
- 1 December 1998
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Design
- Vol. 4 (6) , 481-488
Is Ceramide Signaling A Target for Vascular Therapeutic Intervention?
Today's society is plagued by cardiovascular diseases such as hypertension and atherosclerosis. Research devoted to the study of these diseases has focused, in part, on physiological phenomena responsible for the development and progression of the disease. Peripheral vascular function is one such focal point of research, and identification of cellular mechanisms that regulate vascular contractility and / or cellular proliferation is crucial for the development of new therapeutic interventions to combat these diseases. This review evaluates a new signaling mechanism, the ceramide signaling pathway as a potential target for therapeutic intervention. Special attention is given ceramide signaling in the contexts of vascular reactivity and cell proliferation in the vasculature. While ceramide signaling is a nascent area of vascular research, a growing body of evidence from other physiological systems implicates this new pathway as a potential regulator of contractile and cell proliferative functions within the blood vessel wall.
- 24 June 1998
- Published by Elsevier in European Journal of Pharmacology
- Vol. 349 (2-3) , R9-R10
The role of the endothelium in ceramide-induced vasodilation
- 24 June 1998
- Published by Elsevier in European Journal of Pharmacology
- Vol. 349 (2-3) , R9-R10
The role of the endothelium in ceramide-induced vasodilation